Mediacenter
Interaktiv & Videos
CytoSorb Therapy in critically ill COVID-19 patients – actual results and best practice | Webinar 1
1/8 videos
1
Best Bits | International Expert Meeting | Intensive Care | Manu Malbrain
02:32
2
Best Bits | International Expert Meeting | Intensive Care | Axel Nierhaus
02:25
3
International Experts Meeting | Intensive Care | Full Version | Webinar 1
01:37:05
4
Internationales Expertentreffen | Intensivmedizin | Vollversion | Webinar 1
01:37:05
5
Reunión internacional de expertos | Cuidados Intensivos | Versión completa | Webinar 1
01:37:05
6
Cytokine storm in COVID-19 – are we sure about it? | Didier Payen | Webinar 1
07
7
Overview about current data and latest findings | Axel Nierhaus | Webinar 1
18:26
8
In whom and when to start? Useful tools and practical hints | Manu Malbrain | Webinar 1
13:12
Video abspielen
Video abspielen
Video abspielen
Interaktiv & Videos
SIP OF SCIENCE WITH ZSOLT
1/1 videos
1
SIP OF SCIENCE WITH ZSOLT insights into recent publications | No. 1
40:47
CytoSorb Therapy in Acute on Chronic Liver Failure | Webinar 1
1/6 videos
1
CytoSorb Therapy in Acute on Chronic Liver Failure | Liver | Full Version | Webinar 1
01:31:12
2
CytoSorb Therapy in Acute on Chronic Liver Failure | Leber | Vollversion | Webinar 1
01:31:12
3
Terapia CytoSorb en la fallahepática aguda y crónica | HÍGADO | Versión completa | Webinar 1
01:31:12
4
Background and rationale | Frederik Brozat | Liver Webinar No. 1 | 2021
10:46
5
What are the clinical benefits? | Matthias Schneeweiss | Liver Webinar No. 1 | 2021
11:32
6
Do we have a new method to reduce ammonia? | Stefan Buettner | Liver Webinar No. 1 | 2021
08:34
ECMO und CytoSorb –Nice to have oder doch ein Must have? | Webinar 2021
1/1 videos
1
ECMO und CytoSorb –Nice to have oder doch ein Must have? | Webinar 2021
01:22
Herzmedizin 2021 Digital
1/2 videos
1
Die CytoSorb-Therapie in der Herzchirurgie - neue Daten und klinische Ergebnisse | DGTHG 2021
57:39
2
CytoSorb therapy in cardiac surgery - New data and clinical results | DGTHG 2021
57:39
Behandlung von Hyperinflammation und anderen Komplikationen nach einem herzchirugischen Eingriff | Webinar 3
1/4 videos
1
Internationales Expertentreffen | Herzchirurgie | Vollversion | Webinar 3
01:23:47
2
Wie wir CytoSorb in der täglichen Routine einsetzen | Lars-Uwe Kühne | Webinar 3
11:01
3
ECMO in Kombination mit CytoSorb: Wann, wie und warum? | Leonardo Gottin | Webinar 3
14:43
4
Herausforderung Rhabdomyolyse - Es gibt eine neue Behandlungsoption | Udo Boeken | Webinar 3
07:21
Verbesserung des chirurgischen Outcome bei Hochrisiko Herzpatienten | Webinar No. 2
1/2 videos
1
Patienten mit infektiöser Endokarditis: Meine klinischen Erfahrungen | Daniel Wendt | Webinar 2
17:08
2
Patienten in der Aortenchirurgie: Meine klinischen Erfahrungen | Dr. Yatin Mehta | Webinar 2 | 2021
09:26
Reduce bleeding complications in ticagrelor and rivaroxaban treated patients undergoing emergency Cardiac Surgery | Webinar No. 1
1/4 videos
1
Welcome & Introduction | Stefan Baudis | Webinar 1 | 2021
02:49
2
How bleeding complications and costs can be reduced? | Stephan Geidel | Webinar 1 | 2021
13:07
3
Do we have a novel treatment approach to avoid re-thoracotomies? | Nikola Bradic | Webinar 1 | 2021
12:17
4
Why is it relevant? | Robert F Storey | Webinar 1 | 2021
08:50
DIVI 2020 | Virtuelles CytoSorbents Symposium
1/5 videos
1
Covid-19 und septischer Schock – Welche Gemeinsamkeiten und Unterschiede gibt es? | Axel Nierhaus
17:43
2
Das richtige Timing für einen Therapiebeginn in der Sepsis | Klaus Kogelmann | DIVI 2020
15:20
3
Warum wir eine individuelle Dosisanpassung brauchen | Thomas Köhler | DIVI 2020
15:32
4
Medikamentenentfernung – was wir bisher wissen | Steffen Mitzner | DIVI 2020
14:25
5
Der besondere Fall - Herausforderung fulminante Leptospirose | Achim Jörres | DIVI 2020
11:03
Virtuelles 7. deutschsprachiges CytoSorb Anwendertreffen | Berlin | 2020
1/19 videos
1
Begrüssung | Christian Steiner
08:27
2
Begrüssung | Stefan Baudis
06:48
3
DOKU 7. CytoSorb Anwendertreffen D-A-CH
04:31
4
Langzeit-Follow-up von Patienten mit septischem Schock unter CytoSorb-Behandlung | W. P. Brouwer
12:30
5
Long term outcome in septic shock patients – results of an actual study | W. P. Brouwer
12:31
6
CytoSorb im septischen Schock - neueste Daten aus Österreich | Berthold Bein
03:56
7
Das richtige Timing - der CytoScore als Entscheidungshilfe | Klaus Kogelmann
13:53
8
Das richtige Dosing – hat ein häufiger Adsorberwechsel Einfluss auf das Outcome? | Thomas Köhler
14:07
9
Nach über 1.000 Patienten – Aktuelles über das CytoSorb-Register | Frank Brunkhorst
18:45
10
Unterschiede und Ähnlichkeiten zu Patienten im septischen Schock | Axel Nierhaus
11:47
11
COVID-19 - Was wir gelernt haben | Andreas Faltlhauser
20:24
12
ECMO | 7. CytoSorb Anwendertreffen D-A-CH | Daniel Dürschmied
12:59
13
CytoSorb als Leberunterstützungstherapie - Was wir bisher wissen | Jan Stange
13:46
14
Herausforderung: Akut auf chronisches Leberversagen | Johathan Frederik Brozat, Alexander Koch
13:16
15
Kombination aus Sepsis und akutem Leberversagen nach Sectio | Robert Breitkopf
10:06
16
Fluminante Leptospirose | Achim Jörres
09:04
17
Hämolytisch-urämisches Syndrom (HUS) | Stephan Ziegeler
08:39
18
Tumorlysesyndrom mit Leberversagen | Bartosz Tycszynski, Essen
10:08
19
Schlussworte 7. CytoSorb Anwendertreffen D-A-CH | Christian Steiner & Stefan Baudis
07:04
Kardiotechnikertagung der DGfK & DGTHG | Satelliten Symposium | Berlin | 2020
1/6 videos
1
Herausforderung Endokarditis | Prof. Karl Träger, Ulm | Virtuelle Kardiotechnikertagung 2020
07:21
2
Herausforderung Endokarditis | Stefan Sajgo, Ulm | Virtuelle Kardiotechnikertagung 2020
07:51
3
Warum eine Kombination mit ECMO sinnvoll ist | Dr. Alexander Supady, Freiburg
09:53
4
Warum eine Kombination mit ECMO sinnvoll ist | Prof. Christoph Benk, Freiburg
03:51
5
Entfernung von Ticagrelor und Rivaroxaban zur Vermeidung von Komplikationen und Kosten | K. Hassan
08:35
6
Entfernung von Ticagrelor und Rivaroxaban zur Vermeidung von Komplikationen und Kosten | H. Pioch
06
7th International CytoSorb Users` Meeting | 2020
1/17 videos
1
Welcome | Stefan Baudis & Christian Steiner | 7th International CytoSorb Users` Meeting | 2020
12:37
2
The Rotterdam study – long term outcome in septic shock patients | Can Ince | 7th IUM | 2020
11:12
3
Impact on hemodynamics and shock reversal – we observe it | Konstanty Szuldrzynski | 7th IUM | 2020
09:08
4
The International CytoSorb Registry | Frank Brunkhorst | 7th International CytoSorb Users` Meeting |
15:23
5
The CytoScore – a new tool to optimize the starting point | Klaus Kogelmann | 7th IUM | 2020
13:16
6
Liver support on a higher level – what we already know | Mihai Popescu | 7th IUM | 2020
10:34
7
The right anticoagulation – we have a lot of options | Gilda Cinnella | 7th IUM | Berlin | 2020
20:17
8
Update on drug removal – more pros than cons | Steffen Mitzner | 7th IUM | Berlin | 2020
15:09
9
Rationale for the use of CytoSorb in COVID-19 patients | Axel Nierhaus | 7th IUM | Berlin | 2020
21:27
10
Experiences from Italy | Giorgio Berlot | 7th International CytoSorb Users` Meeting | Berlin | 2020
12:21
11
Experiences from Iran | Amir Ahmad Nassiri | 7th International CytoSorb Users` Meeting | 2020
17:01
12
Experiences from the US | Michael Firstenberg | 7th International CytoSorb Users` Meeting | 2020
12:18
13
Experiences from Latin America | José Ernesto López Almaraz | 7th IUM | Berlin | 2020
14:59
14
Complex case of TTP associated with severe pancreatitis | Stephan Ziegeler | 7th IUM | Berlin | 2020
09:21
15
Cytokine release syndrome after CAR-T-Cell therapy | Gabriella Bottari | 7th IUM | Berlin | 2020
08:37
16
MDMA intoxication | Alexander Supady | 7th International CytoSorb Users` Meeting | Berlin | 2020
06:40
17
Closing remarks | Efthymios Deliargyris | 7th International CytoSorb Users` Meeting | Berlin | 2020
10:35
EACTS | 2020
1/5 videos
1
CytoSorbents Introduction | EACTS 2020
02:34
2
Mitral valve endocarditis – new chances to improve the outcome | Daniel Wendt | EACTS 2020
21:13
3
Aortic surgery – modulation of the inflammatory response | Yatin Mehta | EACTS 2020
10:40
4
Removal of Ticagrelor during emergency heart surgery | Stephan Geidel | EACTS 2020
19:48
5
Successful treatment of rhabdomyolysis following heart transplantation | Udo Boeken | EACTS 2020
12:20
COVID-19 and CytoSorb Therapy | Webinar
1/3 videos
1
Joint Perfusion COVID-19 Task Force Webinar: Rationale and Practical use of CytoSorb
01:31:26
2
Joint Perfusion COVID-19 Task Force: COVID-19 Patient Transport and Cytosorb Use
01:13:57
3
Joint Perfusion COVID-19 Task Force: COVID-19 In Practice Third Webinar
01:01:52
DIVI | 2019 | Hamburg
1/4 videos
1
Schnelle Schockkontrolle in der Sepsis | DIVI | 2019 | Hamburg
17:27
2
Ein früher Therapiebeginn kann das Outcome verbessern | DIVI | 2019 | Hamburg
13:12
3
ECMO plus CytoSorb | DIVI | 2019 | Hamburg
13:56
4
Medikamentendosierung unter CytoSorb: Anpassungen erforderlich | DIVI 2019 | Hamburg
21:34
6. CytoSorb Anwendertreffen DACH | 2019 | Hamburg
1/10 videos
1
Bedeutung der Hämodynamik und Konsequenzen hoher Katecholamindosierungen | Berthold Bein
20:18
2
CytoSorb zur Kreislaufstabilisierung im vasoplegischen Schock | Karl Träger
22:02
3
Wann beginne ich die Therapie? CytoScore als neue Möglichkeit... | Klaus Kogelmann
17:48
4
Aktuelle Daten zur Sicherheit und Antibiotika-Dosierung unter CytoSorb | Steffen Mitzner
31:31
5
Das CytoSorb-Register – Eine aktuelle Zwischenauswertung | Daniel Dürschmied
06:42
6
CytoSorb und Pruritus | Markus Tölle | 6. CytoSorb Anwendertreffen DACH | 2019 | Hamburg
17:45
7
CytoSorb zur Myoglobin-Entfernung | Stephan Klösel
18:24
8
CytoSorb und ECMO - Erfahrungen aus Freiburg | Alexander Supady
17:06
9
CytoSorb und ECMO - Erfahrungen aus Ibbenbüren | Stephan Ziegeler
13:46
10
CytoSorb beim Leberversagen – Rationale und Übersicht der bisherigen Daten | Jan Stange
13:29
EACTS | 2019 | Lisbon | Symposium
1/17 videos
1
Enhanced hemodynamic and metabolic stability in aortic surgery | EACTS | 2019 | Lisbon |
14:20
2
Improved clinical outcome in ECMO patients | EACTS | 2019 | Lisbon |
18:29
3
Intraoperative use in endocarditis -The REMOVE trial | EACTS | 2019 | Lisbon |
17:20
4
Faster control of refractory vasoplegic shock | Nandor Marczin | EACTS 2019
22:45
5
6
Effects on outcome in mitral valve infective endocarditis | Daniel Wendt | EACTS 2019
15:26
7
Reduction of inflammation in heart transplantation | Endre Németh | EACTS | 2019 | Lisbon
17:27
8
Removal of Ticagrelor | Stephan Geidel | EACTS 2019
20:12
9
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019
13:22
10
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
15:32
11
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
15:32
12
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
15:30
13
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
13:22
14
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Polish Subtitles
13:22
15
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
13:22
16
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
13:22
17
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
13:22
EACTS | 2019 | Lisbon | Symposium mit Untertiteln
1/9 videos
1
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | French Subtitles
15:30
2
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
15:32
3
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
15:30
4
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Polish Subtitles
15:30
5
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
15:32
6
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
13:22
7
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
13:22
8
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
13:22
9
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
13:22
ESICM Lives 2019 | Berlin
1/7 videos
1
Improved outcome of patients in septic shock | ESICM Lives 2019: Webcast
24:20
2
3
What makes it unique Rationale of CytoSorb | ESICM Lives 2019: Webcast
20:10
4
Drug removal and safety aspects – what do we currently know | ESICM Lives 2019: Webcast
18:01
5
Improved outcome of patients in septic shock | ESICM Lives 2019: Summary
01:53
6
Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
21:27
7
Jan Stange y Advantages compared to other liver support systems | ESICM Lives 2019: Webcast | SPA
21:27
Sepsis Update 2019 | Weimar | Symposium Webcast
1/4 videos
1
Hemodynamic changes during hemoadsorption – Which parameters matter | Sepsis Update 2019
18:06
2
Timing and dosing as part of an individualized therapy in septic shock | Sepsis Update 2019
16:04
3
How we use CytoSorb in clinical routine | Sepsis Update 2019
11:24
4
What makes it unique? Rationale and background of CytoSorb Therapy | Sepsis Update 2019
14:22
TCS ECMO 2019 | Paris | Symposium Webcast
1/2 videos
1
TCS ECMO 2019 | Paris | Webcast Pappalardo
11:53
2
TCS ECMO 2019 | Paris | Webcast Traeger
27:23
6th International CytoSorb Users` Meeting | 2019 | Brussels
1/10 videos
1
Welcome - 6th International CytoSorb Users` Meeting
09:06
2
My very special CytoSorb case
11:16
3
My clinical experiences after 100 patients
11:48
4
From experiments to evidence: Safety aspects and drug removal
46:58
5
Hemoadsorption modulates pulmonary metabolism and edema formation
11:56
6
CytoSorb in cardiac arrest
11:08
7
CytoScore helps me to find the right starting point
10:26
8
Opening Lecture: Past, present and future of CytoSorb
30:36
9
CytoSorb in various fields of application: Liver failure
15:04
10
What do we know and what do we have to do? CytoSorb in various fields of application: ECMO
11:34
1. Herzchirurgisches CytoSorb Anwendertreffen | 2019 | Wiesbaden
1/8 videos
1
Introduction
10:17
2
Impact of Cytokine Removal during Cardiopulmonary Bypass with CytoSorb
13:39
3
CytoSorb - Anwendung bei Endokarditis
13:20
4
CytoSorb bei Aortendissektion
19:09
5
Impact of Cytokine Removal during Cardiopulmonary Bypass with CytoSorb
08:22
6
CytoSorb Anwendung postoperativ 5 Jahre Erfahrungen im HDZ
12:24
7
CytoSorb und ECMO - Ergebnisse aus Ulm
30:37
8
Intraoperative removal of Ticagrelor to reduce bleeding complications in emergency cardiac Surgery
13:43
5. CytoSorb Anwendertreffen DACH | 2018 | Leipzig
1/5 videos
1
01 Praktische Aspekte und neue Erfahrungen im Bereich Sepsis und systemische Hyperinflammation
01:02:34
2
02 Praktische Aspekte und neue Erfahrungen im Bereich Sepsis und systemische Hyperinflammation
28:22
3
03 Praktische Aspekte und neue Erfahrungen im Bereich Rhabdomyolyse
25:12
4
04 Praktische Aspekte und neue Erfahrungen im Bereich Leberversagen
35:21
5
Dr. Christian Steiner, CytoSorbents | 2018 | Leipzig
10:46
EACTS | 2018 | Milan | Symposium Webcast
1/5 videos
1
MOF in ECMO patients and the impact of CytoSorb therapy – 3 years’ experience
09:19
2
Improved outcome of patients undergoing heart transplant with CytoSorb | EACTS | 2018 | Milan
09:34
3
Clinical effects of intraoperative hemoadsorption in acute infective endocarditis – A case series
10:57
4
5
Intraoperative removal of Ticagrelor to reduce bleeding complications... | EACTS | 2018 | Milan
09:13
CytoSorb Aufbau | Anleitung
1/6 videos
1
CytoSorb-Aufbau: Einsatz im kardiopulmonalen Bypass
02:33
2
CytoSorb-Aufbau: Austausch des Adsorbers
02:15
3
CytoSorb-Aufbau: Einsatz hinter dem Dialysator
03:09
4
CytoSorb Aufbau: Einsatz vor dem Dialysator
02:57
5
Hämoperfusion Aufbau für Stand-Alone Anwendung von CytoSorb
02:09
6
CytoSorb ECMO Integration - Deutsch - Animation
03:36
CytoSorb Testimonials
1/6 videos
1
Future – What do you think about the future of CytoSorb?
01:56
2
Safety – How would you describe the safety profile of CytoSorb?
46
3
Ease of use – How easy is the set-up of CytoSorb?
01:05
4
Clinical effects – What are the most impressive clinical effects when you use CytoSorb?
04:37
5
CytoSorb Testimonials
03:30
6
Early use – When should CytoSorb be started in septic shock?
01:15
Haftungsausschluss
Die Aussagen hier geben nur die persönlichen Meinungen und Ansichten des Sprechers wieder und spiegeln nicht notwendigerweise allgemein anerkanntes medizinisches Wissen oder Indikationen wider, die von der beabsichtigten Verwendung von CytoSorb abgedeckt werden.
CytoSorb darf nur von medizinischem Fachpersonal angewendet werden.